Nancy Wysenski - Dova Pharmaceuticals Independent Director
Director
Ms. Nancy J. Wysenski is Independent Director of the company. Ms. Wysenski has served as a member of our Board of Directors since June 2018. Ms. Wysenski is currently a member of the Board of Directors of Alkermes Pharmaceuticals and Tetraphase Pharmaceuticals. From December 2009 through June 2012, Ms. Wysenski served as the Executive Vice President and Chief Commercial Officer of Vertex Pharmaceuticals. Prior to joining Vertex, she served as Chief Operating Officer of Endo Pharmaceuticals, where she led sales, marketing, commercial operations, supply chain management, human resources, and various business development initiatives. Prior to her role at Endo Pharmaceuticals, Ms. Wysenski participated in the establishment of EMD Pharmaceuticals, Inc., where she held various leadership positions, including President and Chief Executive Officer from 2001 to 2006 and Vice President of Commercial from 1999 to 2001. Before joining EMD Pharmaceuticals, she held several salesfocused roles at major pharmaceutical companies, including Vice President of Field Sales for Astra Merck, Inc since 2018.
| Age | 60 |
| Tenure | 6 years |
| Professional Marks | MBA |
| Phone | 919 748-5975 |
| Web | www.dova.com |
Nancy Wysenski Latest Insider Activity
Tracking and analyzing the buying and selling activities of Nancy Wysenski against Dova Pharmaceuticals stock is an integral part of due diligence when investing in Dova Pharmaceuticals. Nancy Wysenski insider activity provides valuable insight into whether Dova Pharmaceuticals is net buyers or sellers over its current business cycle. Note, Dova Pharmaceuticals insiders must abide by specific rules, including filing SEC forms every time they buy or sell Dova Pharmaceuticals'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Nancy Wysenski over six months ago Exercise or conversion by Nancy Wysenski of 35000 shares of Alkermes Plc subject to Rule 16b-3 |
Dova Pharmaceuticals Management Efficiency
Dova Pharmaceuticals' management efficiency ratios could be used to measure how well Dova Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 22.25 M in liabilities with Debt to Equity (D/E) ratio of 43.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Dova Pharmaceuticals has a current ratio of 5.53, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Dova Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Dova Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Dova Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Dova to invest in growth at high rates of return. When we think about Dova Pharmaceuticals' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Karin Ireton | Academy Sports OutdoorsInc | 59 | |
| JeanGuy Martin | Academy Sports OutdoorsInc | N/A | |
| Alistair Cox | Hasbro Inc | 55 | |
| Paul Hackwell | Playa Hotels Resorts | 36 | |
| Tracy Leinbach | Hasbro Inc | 58 | |
| Andrew Rubin | JD Sports Fashion | 52 | |
| Crispin Davis | Hasbro Inc | 69 | |
| Edward Philip | Hasbro Inc | 53 | |
| Adrian Reynolds | Academy Sports OutdoorsInc | N/A | |
| Martin Davies | JD Sports Fashion | 57 | |
| Elizabeth Lieberman | Playa Hotels Resorts | 65 | |
| Loudon Owen | Academy Sports OutdoorsInc | N/A | |
| Brian Small | JD Sports Fashion | 60 | |
| Graham Freestone | Evolution Mining | N/A | |
| Jane Warner | Brunswick | 73 | |
| Gregory Hunt | Emerson Radio | 57 | |
| Neil Greenhalgh | JD Sports Fashion | 52 | |
| Stephen Millham | Playa Hotels Resorts | 48 | |
| Hope Cochran | Hasbro Inc | 46 | |
| David Everitt | Brunswick | 68 | |
| Lauren Flaherty | Brunswick | 63 | |
Management Performance
| Return On Equity | -1.0E-4 | |||
| Return On Asset | -1.0E-4 |
Dova Pharmaceuticals Leadership Team
Elected by the shareholders, the Dova Pharmaceuticals' board of directors comprises two types of representatives: Dova Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dova. The board's role is to monitor Dova Pharmaceuticals' management team and ensure that shareholders' interests are well served. Dova Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dova Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steven Goldman, Independent Director | ||
| Douglas Blankenship, CFO | ||
| Alfred Novak, Independent Director | ||
| Alex Sapir, President CEO, Director | ||
| Lee Allen, Chief Medical Officer | ||
| Sean Stalfort, Director | ||
| Kevin Laliberte, Senior Vice President - Product Development | ||
| Roger Jeffs, Independent Director | ||
| David Zaccardelli, President CEO | ||
| Nancy Wysenski, Independent Director | ||
| Mark Hahn, CFO, Principal Financial Officer and Principal Accounting Officer | ||
| Paul Manning, Chairman of the Board | ||
| Jason Hoitt, Chief Commercial Officer |
Dova Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dova Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.0E-4 | |||
| Return On Asset | -1.0E-4 | |||
| Profit Margin | (0.06) % | |||
| Operating Margin | (541.38) % | |||
| Current Valuation | 380.37 M | |||
| Shares Outstanding | 28.8 M | |||
| Shares Owned By Insiders | 62.25 % | |||
| Shares Owned By Institutions | 40.63 % | |||
| Number Of Shares Shorted | 1.19 M | |||
| Price To Earning | (12.63) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Dova Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Dova Pharmaceuticals' short interest history, or implied volatility extrapolated from Dova Pharmaceuticals options trading.
Pair Trading with Dova Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dova Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dova Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Union Pacific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Union Pacific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Union Pacific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Union Pacific to buy it.
The correlation of Union Pacific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Union Pacific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Union Pacific moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Union Pacific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Dova Stock
If you are still planning to invest in Dova Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dova Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |